/other/Diamyd_Medical_AB_publ-logo.png?Expires=1749521385&Signature=TNKyEEdJ8K~K1fp9A8NCT21idSOU~s5TGHtB5vy56zFezQHrJ4HsYFu7T4mt526CXzJ-CYATA4uiaC9uCnlO9YlEjAD6qA~zWtM3WDbA0eR6-babUAA2JRPEw5EdJ4Uzh5F3nV0G~GBMuxXrsme1NWRMfz-m9S68MRHRr4S7bMZWFlrJmX7Cc2RdKE8pUhXNEDh-oqkYXU00AxrBHT-bvotqnZ2y~nCHpYrpoqySKq0w-1FYYzbcE3Oi8169OHYWZk6b4puTtnJx5vE~FBbveUR3WrEAuPGPPo9de~vUWmBKIoxrISWYJRmK8OaGgHuYzlNOWDY~2V8fVX4sHtqm1Q__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
Diamyd Medical AB (publ)
DMYD | FN
Overview
Corporate Details
- ISIN(s):
- SE0005162872 (+5 more)
- LEI:
- 5493003NP2HNQDEKB804
- Country:
- Sweden
- Address:
- BOX 7349, 103 90 STOCKHOLM
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Diamyd Medical AB is a biotech company working on precision medicine for autoimmune diabetes. They are developing antigen-specific immunotherapies.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Ascelia Pharma | Sweden | ACE | |
|
Atrys Health S.A. | Spain | ATRY | |
|
AUKETT SWANKE GROUP PLC | United Kingdom | AUK | |
|
Azorean - Aquatic Technologies S.A. | Portugal | MLAAT | |
|
Bachem Holding AG | Switzerland | BANB | |
|
Bavarian Nordic | Denmark | BAVA | |
|
BB Biotech AG | Switzerland | BION | |
|
BEEKS FINANCIAL CLOUD GROUP PLC | United Kingdom | BKS | |
|
BenevolentAI | United Kingdom | BAI | |
|
BerGenBio | Norway | BGBIO |